Scientists have claimed a major breakthrough in the battle against Alzheimer’s by neutralising a key gene that significantly increases the risk of developing the disease.
The research, published in the journal Nature, reveals how the apoE4 gene confers its risk for Alzheimer’s in human brain cells.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“What’s more, they were able to erase the damage caused by apoE4 by changing it, with a small molecule, into a harmless apoE3-like version”, says news website ScienceDaily.
Having one copy of the apoE4 gene “more than doubles a person’s likelihood of developing Alzheimer’s disease, whereas having two copies increases the risk 12-fold”, says the Telegraph.
Previous studies “have indicated that roughly one in four people carry the gene”, the newspaper reports.
The latest breakthrough adds to hopes of finding a drug treatment that could halt the onset of the disease. The researchers have urged caution, however, pointing out that the neutralising process has only been tried in lab conditions as yet.
The development came after the California team decided to shun traditional testing methods.
Most Alzheimer’s research and drug development “are done in mouse models of the disease”, says ScienceDaily.
“Drug development for Alzheimer's disease has been largely a disappointment over the past ten years,” says lead study author Yadong Huang. “Many drugs work beautifully in a mouse model, but so far they’ve all failed in clinical trials. One concern within the field has been how poorly these mouse models really mimic human disease.”
Following a succession of clinical trial failures, Huang and his colleagues decided to use human cells to model the disease and test new drugs, leading to their discovery.
-
How Manchesterism could change the UKThe Explainer The idea involves shifting a centralized government to more local powers
-
Church of England instates first woman leaderSpeed Read Sarah Mullally became the 106th Archbishop of Canterbury
-
Fed holds rates steady, bucking Trump pressureSpeed Read The Federal Reserve voted to keep its benchmark interest rate unchanged
-
Israel retrieves final hostage’s body from GazaSpeed Read The 24-year-old police officer was killed during the initial Hamas attack
-
China’s Xi targets top general in growing purgeSpeed Read Zhang Youxia is being investigated over ‘grave violations’ of the law
-
Panama and Canada are negotiating over a crucial copper mineIn the Spotlight Panama is set to make a final decision on the mine this summer
-
Why Greenland’s natural resources are nearly impossible to mineThe Explainer The country’s natural landscape makes the task extremely difficult
-
Iran cuts internet as protests escalateSpeed Reada Government buildings across the country have been set on fire
-
US nabs ‘shadow’ tanker claimed by RussiaSpeed Read The ship was one of two vessels seized by the US military
-
How Bulgaria’s government fell amid mass protestsThe Explainer The country’s prime minister resigned as part of the fallout
-
Femicide: Italy’s newest crimeThe Explainer Landmark law to criminalise murder of a woman as an ‘act of hatred’ or ‘subjugation’ but critics say Italy is still deeply patriarchal
